Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

HC Wainwright & Co. Reiterates Neutral on Paratek Pharmaceuticals, Maintains $2.15 Price Target

Author: Benzinga Newsdesk | August 07, 2023 06:57am

HC Wainwright & Co. analyst Ed Arce reiterates Paratek Pharmaceuticals (NASDAQ:PRTK) with a Neutral and maintains $2.15 price target.

Posted In: PRTK